Explore data for an FDA-approved treatment option in HR+, HER2- breast cancer in certain adjuvant or metastatic settings

//

Estimated Read Time:

1 minute

December 9, 2022 @ 10:00 am 11:00 am CST

Details

Date:
December 9, 2022
Time:
10:00 am – 11:00 am CST
Event Category: